
Loading, please wait...

Loading, please wait...

The recently released National Health Accounts (NHA) 2022-23 estimates expose dramatic regional imbalances in Indian State Health Spending. While several northeastern states allocate substantial resources to healthcare, many wealthy states spend very little. In fact, many of India's richest states spend less than 1% of their Gross State Domestic Product (GSDP). Consequently, these spending gaps raise critical questions about public healthcare access and equitable infrastructure development across the country.
Specifically, Manipur led the country by spending 5.5% of its GSDP on health, up from 4.6% in 2021-22. Similarly, Meghalaya dedicated 4.4% of its economic output to healthcare, whereas Nagaland and Mizoram recorded 3.6% and 3.2% respectively. In contrast, several highly industrialized states failed to meet the 1% threshold. For instance, Karnataka's spending plummeted from 1.1% to 0.7% of its GSDP. Additionally, Maharashtra and Tamil Nadu saw their health allocations drop to 0.8% and 0.9% respectively. These declines occurred largely because the extraordinary, one-time pandemic expenditures of the previous year finally wound down.
Besides GSDP ratios, the report highlights major differences in per capita government healthcare expenditure. Puducherry recorded the highest per capita public health spending at Rs 10,675 among Union Territories with a legislature. Conversely, Uttar Pradesh reported one of the lowest per capita spends at Rs 1,419, followed closely by Jharkhand and Madhya Pradesh. Nevertheless, due to its massive population base, Uttar Pradesh registered the highest total public health expenditure at Rs 33,352 crore. This high total spending stands in stark contrast to its very low per capita delivery. Consequently, public healthcare experts emphasize that high aggregate spending does not automatically translate into adequate individual patient care.
This uneven financial distribution presents serious hurdles as states battle a rising burden of non-communicable diseases. Additionally, an aging demographic profile is steadily driving up clinical care costs. Therefore, the lack of robust public healthcare spending forces many families to depend on expensive private medical systems. To reverse this trend, state policymakers must prioritize systematic investment in primary and secondary healthcare infrastructure.
Q1: Why did healthcare spending decrease in some states in 2022-23 compared to the previous year?
Healthcare spending in 2021-22 was exceptionally high due to emergency COVID-19 vaccination drives and pandemic-related infrastructure expansion. Consequently, normal funding levels resumed in 2022-23.
Q2: Which state recorded the highest proportion of its GSDP spent on healthcare?
Manipur spent the highest proportion of its GSDP on healthcare, allocating 5.5% in 2022-23.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A detailed analysis of the National Health Accounts 2022-23 data, highlighting the healthcare spending disparities between smaller and larger Indian states....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today